Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- (-) Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- (-) Health Spending
- (-) Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Display Only
Showing 150 Results
NPC in Health Affairs Blog: It’s Time for a Serious Conversation About Health Care Spending
In a blog published today in Health Affairs, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, noted that a serious conversation among all health care stakeholders is…
Where Are They Now: Checking In With Former NPC Fellow Chuck Shih
Chuck Shih, PhD, MHS, currently Senior Officer, Drug Spending at Pew Charitable Trusts, was the 2013-2015 NPC Health Policy Fellow as part of a partnership with the George Washington University…
What’s Contributing to Unnecessary Health Spending?
Reducing low-value care—health care that is cost-inefficient and clinically ineffective—remains a front burner issue for health care stakeholders. It hasn’t been easy to root out or measure low-value…
What Kinds of Information Do Payers and Providers Want for Decision-Making?
A new white paper from Xcenda/AmerisourceBergen and NPC highlights survey findings from payers and providers on what types of evidence are most important to them when it comes to making population…
An Opportunity to Thoughtfully and Holistically Address Health Care Spending
The Medicare Trustees Annual Report issued last week was a mix of positive news and a stark reminder that we need to find thoughtful solutions to ensure that the Medicare program will remain solvent…
CER Collaborative Helps Health Care Decision-Makers Assess Evidence
A feature article in this month's Value and Outcomes Spotlight highlights the importance of comparative effectiveness research (CER) and details the CER Collaborative Initiative, a joint effort by…
NPC @ DIA 2017 Annual Meeting: Exploring Comparative Effectiveness Research
NPC Chief Science Officer and Executive Vice President Robert Dubois, MD, PhD, will address how comparative effectiveness research is being used by health care decision-makers at the Drug Information…
Asking the Right Questions About Our Health Care System Costs
With health news headlines focused on drug prices, the Senate Committee on Health, Education, Labor and Pensions is holding a hearing today titled, "The Cost of Prescription Drugs: How the Drug…
How Are Health Plans Using Patient Data to Improve Outcomes?
Health plans collect enormous amounts of data through electronic health records, administrative claims, mobile health devices and other sources. Is the data simply sitting on a shelf, or is it being…
NPC Submits Comments to FDA on Exchange of Clinical and Economic Information
To achieve our shared goal of a high-performing, value-based health care system, informed and evidence-based decisions are needed. Greater efficiency and better care requires more information…
Concerns Around Budget Impact Thresholds: Not All Drugs Are The Same
A study published in Value in Health explores the potential impact of using budget thresholds as budget caps (e.g., cannot spend more than a set dollar amount) for individual drugs.
FDA Releases Guidance Documents on Communicating Clinical and Economic Information
The Food and Drug Administration (FDA) this week has released a series of draft guidance documents that clarify how and when different types of clinical and economic information may be communicated.
Pre-Approval Information Exchange Can Help Improve Population Health Decision-Making
Health care stakeholders, including NPC, gathered in September for a meeting hosted by the Academy of Managed Care Pharmacy to discuss potential ways to improve the exchange of information between…
NPC’s Dr. Jennifer Graff Testifies Before FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Devices
NPC Vice President for Comparative Effectiveness Research Jennifer Graff, PharmD, highlighted two key issues in her testimony at the Food and Drug Administration public hearing on manufacturer…
Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges
This study provides an early evaluation of the CER Collaborative's training program's impact on learners’ self-reported abilities to evaluate and incorporate comparative effectiveness research…
2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
NPC's sixth annual survey of stakeholder views on comparative effectiveness research (CER) and the environment for health care decision-making found that stakeholders continue to have a high…
What Contributes Most to High Health Care Costs?
A small segment of the population—often the sickest patients—drive the majority of health care spending. This study, which examined the spending patterns for these high resource patients (HRP), …
Developing Evidence that is Fit for Purpose: A Framework for Payer and Research Dialogue
A study published in the September 2015 issue of The American Journal of Managed Care introduces a framework developed by the National Pharmaceutical Council (NPC) and AcademyHealth that could help…
Translating Comparative Effectiveness Research into Medicaid Payment Policy: Views from Medical and Pharmacy Directors
NPC supported a survey of Medicaid medical and pharmacy directors to better understand how policy makers in the state Medicaid programs view comparative effectiveness research (CER) and how they use…
2015 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
NPC's fifth annual survey, "Comparative Effectiveness Research and the Environment for Health Care Decision-Making," provides a snapshot of stakeholders’ perceptions of the key players in the…